Virus-like particles produced in plants as potential vaccines.

Expert Rev Vaccines

CNR-IGV, National Research Council of Italy, Institute of Plant Genetics, Via Università 133, 80055 Portici, Napoli, Italy.

Published: February 2013

Virus-like particles (VLPs) have been produced as candidate vaccines in plants virtually since the introduction of biofarming. Even today, VLPs remain the best candidates for safe, immunogenic, efficacious and inexpensive vaccines. Well-characterized human animal viruses such as HBV, HCV, HIV and HPV, rotaviruses, norovirus, foot and mouth disease viruses and even influenza virus proteins have all been successfully investigated for VLP formation. Proteins have been produced in transgenic plants and via transient expression techniques; simple structures, structures depending on more than one protein, naked and enveloped particles have all been made. There have been multiple proofs of concept, more than a few proofs of efficacy, and several products moved into human trials. This review will cover the history of VLP production in plants, and will explore a few examples in detail to illustrate the potential of such a mode of production for human and animal medicine.

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.12.147DOI Listing

Publication Analysis

Top Keywords

virus-like particles
8
human animal
8
particles produced
4
plants
4
produced plants
4
plants potential
4
potential vaccines
4
vaccines virus-like
4
particles vlps
4
vlps produced
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!